ConforMIS is a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants that are individually sized and shaped, which it refers to as customized, to fit each patient's anatomy. Co. provides a line of knee replacement implants, both partial and total. These products include: iTotal CR, a cruciate-retaining, customized total knee replacement system; iTotal PS, a posterior cruciate ligament substituting, or posterior-stabilized, customized total knee replacement product; iDuo, a customized bicompartmental knee replacement system; and iUni, a customized unicompartmental knee replacement product. The CFMS stock yearly return is shown above.
The yearly return on the CFMS stock yearly return page and across the coverage universe of our site,
is a measure of the annual return over the calendar year 2020 for the given stock.
When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is
more than just the change in price if that instrument pays a dividend or coupon.
One way to factor dividends into the return is simply to count them as cash — we don't do
that here. Instead, our website aims to empower investors
by performing the CFMS annual return calculation with any dividends reinvested as applicable (on ex-dates).
|